Manganese‐CpG Nanocomposite Integrates ROS‐Induced Cell Apoptosis and STING‐Activated and Adjuvant‐Augmented Immune Responses for Tumor Elimination and Prevention-Reference-Cited by-同舟云学术

Manganese‐CpG Nanocomposite Integrates ROS‐Induced Cell Apoptosis and STING‐Activated and Adjuvant‐Augmented Immune Responses for Tumor Elimination and Prevention

Published:2022-12-08 Issue:3 Volume:6 Page:2200175
ISSN:2366-3987
Container-title:Advanced Therapeutics
language:en
Short-container-title:Advanced Therapeutics

Author:

Chen Jie¹²,Lu Jianxiu¹²,Shan Yunyi¹²,Wang Yanqiu¹²,Xu Zhilong³,Xi Juqun¹²,Fan Lei³,Gao Lizeng⁴^ORCID

Affiliation:

1. School of Medicine Institute of Translational Medicine Yangzhou University Yangzhou 225009 P. R. China

2. Jiangsu Key Laboratory of Integrated Traditional Chinese and Western Medicine for Prevention and Treatment of Senile Diseases Yangzhou 225009 P. R. China

3. School of Chemistry and Chemical Engineering Yangzhou University Yangzhou 225002 P. R. China

4. CAS Engineering Laboratory for Nanozyme Key Laboratory of Protein and Peptide Pharmaceutical Institute of Biophysics Chinese Academy of Sciences Beijing 100101 P. R. China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Pharmacology (medical),Biochemistry (medical),Genetics (clinical),Pharmaceutical Science,Pharmacology,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/adtp.202200175

Reference42 articles.

1. Tumor Ablation and Nanotechnology

2. Current developments in nanotechnology for improved cancer treatment, focusing on tumor hypoxia

3. Cancer nanomedicine: progress, challenges and opportunities